Vir Biotechnology, Inc. (NASDAQ:VIR) Given Average Recommendation of "Moderate Buy" by Analysts
Shares of Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the eleven analysts that are presently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, one has given a ho
Source link